#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pseudomyxoma peritonei Bile acid synthesis disorder Small cell lung cancer Cutaneous T-cell lymphoma stage II Retinal artery occlusion Raynaud's phenomenon Hypotransferrinaemia Cutaneous T-cell lymphoma refractory B-cell lymphoma recurrent Haematological malignancy Amyloidosis Bronchiolitis Hypertriglyceridaemia Neuromyelitis optica spectrum disorder Cytokine release syndrome More trials…

    Learn about Rare Diseases

    Synovial sarcoma metastatic – Trials in Disease Anaplastic thyroid cancer – Diagnostics Ornithine transcarbamoylase deficiency – Life with Disease IgA nephropathy – Diagnostics Langerhans cell sarcoma – Diagnostics Hereditary motor and sensory neuropathy – Treatment Angiosarcoma non-metastatic – Basic Information Nephrotic syndrome – Diagnostics Synovial sarcoma recurrent Cytokine release syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Epinephrine 534 Atropine Sulfate Monohydrate Perindopril Tert-Butylamine Lasofoxifene Enalapril Evolocumab Wt1 Mrna Dc Tumor Necrosis Factor-Alpha Gallium (68Ga) Psma-R2 Treosulfan Alanyl Glutamine IMA401 Bupropion Hydrochloride Ondansetron Riociguat Izorlisib Mesilate Metamizole Bi 685509 CHLORMADINONE ACETATE More therapies…

    Learn about Your Condition

    Hydrocephalus Cryoglobulinaemia Castleman's disease Diabetic gastroparesis Anaemia of pregnancy Diabetic neuropathy Infant sedation Anxiety Fracture infection Atrophic vulvovaginitis Bone marrow disorder Congenital ureteric anomaly Skin cancer Kawasaki's disease Rectal cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pathological Conditions, Signs and Symptoms

  • Study of serotonin system changes in early Parkinson’s disease using [11C]DASB and [11C]SB207145 PET imaging in people with SNCA gene mutations

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • (1-(11C)METHYLPIPERIDIN-4-YL)METHYL 5-AMINO-6-CHLORO-1,4-BENZODIOXINE-8-CARBOXYLATE
    • 3-AMINO-4-[2-[[METHYL((111C)METHYL)AMINO]METHYL]PHENYL]SULFANYLBENZONITRILE
    France

  • Study on the Effectiveness of Early PSMA-PET Scans with Gozetotide in Patients with Metastatic Renal Cancer Undergoing Standard Immunotherapy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Clear cell renal cell carcinoma
    Investigated Drugs:
    • Gozetotide
    Belgium

  • Evaluation of tamsulosin and furosemide combination therapy after shock wave lithotripsy in patients with kidney stones

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Nephrolithiasis
    Investigated Drugs:
    • Furosemide
    • Tamsulosin Hydrochloride
    • Ibuprofen
    Denmark

  • Study on Etoposide for Patients with Severe Hemophagocytic Lymphohistiocytosis in Intensive Care

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemophagocytic lymphohistiocytosis
    Investigated Drugs:
    • Etoposide
    France

  • Study Comparing Short-Course and Long-Course Chemotherapy with mFOLFIRINOX or PAXG for Patients with Stage I-III Pancreatic Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Ductal adenocarcinoma of pancreas
    Investigated Drugs:
    • Gemcitabine
    • Irinotecan Hydrochloride Trihydrate
    • Calcium Folinate Pentahydrate
    Italy

  • Study of tamsulosin and furosemide combination therapy for patients after shock wave lithotripsy of kidney stones

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Nephrolithiasis
    Investigated Drugs:
    • Furosemide
    • Tamsulosin Hydrochloride
    • Ibuprofen
    Denmark
Previous Page
1 … 12 13 14 15 16 … 21
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!